MONTANOVA CAPITAL, LLC bought BNTC
December 26, 2025 · Form 4 insider transaction
MONTANOVA CAPITAL, LLC bought 14,320 shares of Benitec Biopharma Inc. at $13.10 per share, a transaction worth $187.6K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
14,320
Price
$13.10
Total value
$187.6K
InsiderMONTANOVA CAPITAL, LLC
RoleDirector, 10% owner
SecurityCommon stock, par value $0.0001 per share
Transaction codeP: Open-market purchase
Transaction dateDecember 26, 2025
Filing dateDecember 29, 2025
Shares owned after9,634,395
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
Notes are included on Exhibit 99.1.; Notes are included on Exhibit 99.1.